Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RAS TRANSGENIC MICE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Germano, D; Pacilio, C; Cancemi, M; Cicatiello, L; Altucci, L; Petrizzi, VB; Sperandio, C; Salzano, S; Michalides, RJAM; Taya, Y; Bresciani, F; Weisz, A
      Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1

      BREAST CANCER RESEARCH AND TREATMENT
    2. Cox, AD
      Farnesyltransferase inhibitors - Potential role in the treatment of cancer

      DRUGS
    3. End, DW; Smets, G; Todd, AV; Applegate, TL; Fuery, CJ; Angibaud, P; Venet, M; Sanz, G; Poignet, H; Skrzat, S; Devine, A; Wouters, W; Bowden, C
      Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro

      CANCER RESEARCH
    4. Guilbaud, N; Kraus-Berthier, L; Meyer-Losic, F; Pierre, A; Hickman, J
      New approaches in experimental oncology: In search of therapeutic models

      BULLETIN DU CANCER
    5. Stickney, JT; Buss, JE
      Murine guanylate-binding protein: Incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding protein

      MOLECULAR BIOLOGY OF THE CELL
    6. Eskens, FALM; Verweij, J
      Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    7. Nielsen, LL
      Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide inpreclinical cancer models

      ONCOLOGY REPORTS
    8. Ding, CZ; Hunt, JT; Ricca, C; Manne, V
      3-imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    9. Zujewski, J; Horak, ID; Bol, CJ; Woestenborghs, R; Bowden, C; End, DW; Piotrovsky, VK; Chiao, J; Belly, RT; Todd, A; Kopp, WC; Kohler, DR; Chow, C; Noone, M; Hakim, FT; Larkin, G; Gress, RE; Nussenblatt, RB; Kremer, AB; Cowan, KH
      Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer

      JOURNAL OF CLINICAL ONCOLOGY
    10. Shi, B; Yaremko, B; Hajian, G; Terracina, G; Bishop, WR; Liu, M; Nielsen, LL
      The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    11. Nielsen, LL; Shi, B; Hajian, G; Yaremko, B; Lipari, P; Ferrari, E; Gurnani, M; Malkowski, M; Chen, JP; Bishop, WR; Liu, M
      Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models

      CANCER RESEARCH
    12. Kerbel, RS
      What is the optimal rodent model for anti-tumor drug testing?

      CANCER AND METASTASIS REVIEWS
    13. LAVELLE F
      PRECLINICAL EVALUATION OF ANTICANCER DRUGS

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 11:54:37